Inhoudsopgave:
|
\u003cp\u003e\u003ci\u003eCovid-19 and Parkinsonism, Volume 165\u003c/i\u003e in the \u003ci\u003eInternational Review in Neurobiology\u003c/i\u003e series, highlights new advances in the field with this new volume presenting interesting chapters that cover a variety of topics, including Parkinsonism associated with viral infections, Covid-19 and nervous system pathology: bench to bedside, Prevalence of Covid-19 in Parkinsonâs Disease: acute settings and hospital, Covid-19 and Parkinsonâs Disease: clinical features, long COVID, Smell deficits in Covid-19 and possible links with Parkinsonâs Disease, Spotlight on non-motor symptoms and Covid-19, and a Summary of treatment paradigms in Parkinsonâs Disease patients and Covid-19.\u003c/p\u003e \u003cp\u003eAdditional sections cover Covid-19 and Parkinsonâs Disease: nursing care, vaccination, telemedicine services, impact on advanced therapies, Covid-19-induced parkinsonism: Real life phenoconversion cases, Loneliness and impact of lockdown on Parkinsonâs Disease patients during the Covid-19 pandemic, Parkinsonâs Disease and Covid-19: Impact of ethnicity and palliative care, and more.\u003c/p\u003e\u003cul\u003e \u003cli\u003eProvides the authority and expertise of leading contributors from an international board of authors\u003c/li\u003e \u003cli\u003ePresents the latest release in the \u003ci\u003eInternational Review of Neurobiology\u003c/i\u003e series\u003c/li\u003e \u003cli\u003eUpdated release includes the latest information on COVID-19 and Parkinsonism\u003c/li\u003e\u003c/ul\u003e |
nl
en